Molbio Diagnostics Limited (MOLBIO.BO) Stock Overview
Explore Molbio Diagnostics Limited’s financial performance, market position, analyst ratings, and future outlook.
Molbio Diagnostics Limited (MOLBIO.BO)
Key Financials
Key Financials
Market Cap
148.5B
P/E Ratio
N/A
EPS (TTM)
$11.58
ROE
N/A
MOLBIO.BO Stock Analysis & Investment Overview (BSE)
Our AI-powered analysis of Molbio Diagnostics Limited (BSE: MOLBIO.BO) gives investors deep insight into how the stock performs on the BSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Molbio Diagnostics Limited's BSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MOLBIO.BO on the BSE shows an RSI of 56.52, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the BSE listing.
Key metrics behind Molbio Diagnostics Limited's BSE-traded stock include a P/E ratio of N/A and a market capitalization of 148.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MOLBIO.BO on the BSE.